Refresh

Venmax Drugs & Pharmaceuticals Ltd. - Research Center

531015 VENMAX Group (Z) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

- - 0.17 0.47 0.15
Expenses

Material consumed

- - 0.29 0.32 0.09

Manufacturing expenses

- - - - -

Personnel expenses

0.03 0.01 0.06 0.22 0.10

Selling expenses

- - - - -

Adminstrative expenses

0.16 0.12 0.14 0.19 0.20

Expenses capitalised

- - - - -

Cost of sales

0.19 0.13 0.50 0.73 0.39

Operating profit

-0.19 -0.13 -0.33 -0.25 -0.24

Other recurring income

0.42 1.98 0.18 - -

Adjusted PBDIT

0.23 1.86 -0.15 -0.25 -0.23

Financial expenses

- - - - -

Depreciation

0.01 0.01 0.01 0.01 0.01

Other write offs

- - - - -

Adjusted PBT

0.23 1.85 -0.16 -0.27 -0.24

Tax charges

- - - 0.01 -

Adjusted PAT

0.23 1.85 -0.16 -0.27 -0.24

Non recurring items

- - - - -

Other non cash adjustments

- - - - -

Reported net profit

0.23 1.85 -0.16 -0.27 -0.24

Earnigs before appropriation

-6.68 -6.91 -8.76 -8.59 -8.32

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-6.68 -6.91 -8.76 -8.59 -8.32
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com